The New and Improved Journal
Interventions for Mild Cognitive Impairment and Alzheimer Disease
Drug Development and Alzheimer Disease
Use of Cholinesterase Inhibitors in Clinical Practice
Imaging-Based Measures of Disease Progression in Clinical Trials of Disease-Modifying Drugs for Alzheimer Disease
Impact of Study Design and Patient Population on Outcomes From Cholinesterase Inhibitor Trials
Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease
Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients
Usefulness of Plasma Haloperidol Levels for Monitoring Clinical Efficacy and Side Effects in Alzheimer Patients With Psychosis and Behavioral Dyscontrol
Effect of Light on Agitation in Institutionalized Patients With Severe Alzheimer Disease
Sedative-Hypnotic Use of Diphenhydramine in a Rural, Older Adult, Community-Based Cohort
Executive Dysfunction and Apathy Predict Functional Impairment in Alzheimer Disease
Apathy and Executive Dysfunction in Mild Cognitive Impairment and Alzheimer Disease
Agitation and Depression in Frail Nursing Home Elderly Patients With Dementia
17β-Estradiol Reduces Plasma Aβ40 for HRT-Naïve Postmenopausal Women With Alzheimer Disease
A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease
Semantic Interference in Mild Alzheimer Disease
A Structured, Open Trial of Risperidone Therapy for Delusions of Theft in Alzheimer Disease
Treatment-Related Decisional Capacity
Integrating Clinical and Ethical Dimensions of Capacity Assessments